Prosecution Insights
Last updated: July 17, 2026
Application No. 18/709,585

Method for purifying sucralose-6-ester

Non-Final OA §112
Filed
May 13, 2024
Priority
Jul 07, 2021 — nonprovisional of PCTCN2021104937
Examiner
OLSON, ANDREA STEFFEL
Art Unit
Tech Center
Assignee
Anhui Jinhe Industrial Co. Ltd.
OA Round
1 (Non-Final)
62%
Grant Probability
Moderate
1-2
OA Rounds
11m
Est. Remaining
50%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
881 granted / 1415 resolved
+2.3% vs TC avg
Minimal -12% lift
Without
With
+-12.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 1m
Avg Prosecution
47 currently pending
Career history
1471
Total Applications
across all art units

Statute-Specific Performance

§101
0.4%
-39.6% vs TC avg
§103
55.5%
+15.5% vs TC avg
§102
8.6%
-31.4% vs TC avg
§112
6.0%
-34.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1415 resolved cases

Office Action

§112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Detailed Action This application is a national stage application of PCT/CN2021/104937, filed July 7, 2021. Claims 1-12 are pending in this application and examined on the merits herein. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 2 and 4-12 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. These claims all include a limitation defining a first range, followed by a second limitation including the term “preferably” and a second, narrower range. These instances are as follows: Claim 2 – “to -10 to 30OC, preferably to 0 to 10OC.” Claim 4 – “a mass ratio of 1-3:1, preferably 1.5-2:1,” “5-15OC, preferably 0-5OC,” and “2-12 hours, preferably 6-10 hours.” Claim 5 – “15-40%, preferably 25-35%,” and “5-20%, preferably 10-15%.” Claim 6 – “The oxidation reaction is -10 to 20OC, preferably to 0 to 10OC;” and “1-12h, preferably 6-10h.” Claim 7 – “the alkaline hydrolysis agent is one or more of ammonia, triethylamine, diethylamine and dimethylamine; preferably, the alkaline hydrolysis agent is dimethylamine,” and “the concentration of dimethylamine is 10%-45 wt%, preferably 30%-40 wt%.” Claim 8 – “the reaction temperature of the alkaline hydrolysis reaction is set to be -10 to 30°C, preferably 0 to 10°C,” “3-12 h, preferably 6-10 h;” and “7-12, preferably 9-10.” Claim 9 – “6-8, preferably7, “heating to 30-60°C, preferably 40-50°C,” “the acidic substance is sulfuric acid, acetic acid or hydrochloric acid, preferably hydrochloric acid;” and “10-35%, preferably 25-30%.” Claim 10 – “0.5-4:1, preferably 1-2:1” Claim 11 – “30-80°C, preferably 35-55°C;” “-0.050 MPa to -0.99 MPa, preferably from -0.50 MPa to -0.8 MPa;” and “1-2 g/cm³, preferably 1.1-1.5 g/cm³.” Claim 12 – “2-24 h, preferably 6-12 h;” and “-10 to 15°C, preferably 0 to 5°C.” Reasons for Allowance Claims 1 and 3 are seen to be allowable. In particular, Applicant’s attention is directed to PCT international publication WO2008/084498 (Reference included with PTO-892) This publication, representing the closest prior art, describes a process for producing 4,1’,6’-trichlorogalactosucrose, (TGS) which is a synonym for sucralose, by 6-acetylating and then chlorinating sucrose. (p. 1 lines 10-21) This reference is specifically directed to a process for removing coloring impurities from this reaction mass that involves oxidizing the crude reaction mixture with ozone. (p. 2 lines 19-24) This somewhat resembles the claimed process in that it involves removing impurities using an oxidation step. However, even when this ozone treatment is performed on the 6-acetyl TGS, it is unclear whether it has the claimed effect of converting some portion of the impurities in the crude reaction mixture into sucralose-6-ester. Rather, based on the disclosure of WO2008/084498 the intent of the ozone treatment is to remove colored impurities described as “ a mixture of caramel, furfurals, etc.” There is no reason to believe that ozonolysis of these colored compounds followed by alkaline hydrolysis would convert any portion of them into sucralose-6-ester. Similarly, US pre-grant publication 2010/0160625 (cited in PTO-892) describes a process for the production of sucralose wherein a side product of the chlorination reaction (deacetylated TGS) is reacylated to reform 6’-O-acyl TGS, which is more easily purified from the reaction mixture than its deacylated counterpart. (See p. 1 paragraphs 2-4) However, while conceptually similar to the process of claim 1, this process does not utilize an oxidation or alkaline hydrolysis step. Conclusion Claims 2 and 4-12 are rejected. Claims 1 and 3 are seen to be allowable. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ANDREA OLSON whose telephone number is (571)272-9051. The examiner can normally be reached M-F 6am-3:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Y Goon can be reached at 571-270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ANDREA OLSON/Primary Examiner, Art Unit 1693 6/24/2026
Read full office action

Prosecution Timeline

May 13, 2024
Application Filed
Jun 26, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673070
TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA
3y 9m to grant Granted Jul 07, 2026
Patent 12668790
LYSIS, BINDING AND/OR WASH REAGENT FOR ISOLATING AND/OR PURIFYING NUCLEIC ACIDS
4y 3m to grant Granted Jun 30, 2026
Patent 12668577
COMPOUNDS, COMPOSITIONS, AND METHODS FOR ISOLATION OF NUCLEIC ACIDS
3y 2m to grant Granted Jun 30, 2026
Patent 12668669
Method for Preparing Cellulose and Lignin Oil by Depolymerizing Lignocellulose Without Exogenous Hydrogen
3y 3m to grant Granted Jun 30, 2026
Patent 12662494
OPTICALLY ACTIVE BRIDGED PIPERIDINE DERIVATIVE
5y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
62%
Grant Probability
50%
With Interview (-12.2%)
3y 1m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1415 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month